LATEST PSYCHEDELICS STOCKS NEWS

M & A48 views6 min read

Red Light Holland to Host a Live Stream on the Company’s Social Media Handles, Including www.youtube.com/redlightholland at 8:30 am Eastern Time on Thursday, June 17th to Discuss Previously Announced Merger with Creso Pharma and Formation of the HighBrid Lab(TM)

Creso Pharma
Todd Shapiro, Bruce Linton, William Lay and Adam Blumenthal to PresentToronto, Ontario--(Newsfile Corp. - June 16, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland") is pleased to announce that it will host a live stream with a supplemental presentation alongside Creso Pharma Limited (ASX: CPH) ... Read More...
58 views1 min read

Silo Pharma Submits Application for NASDAQ up-listing

Silo Pharma
Englewood Cliffs, NJ, May 25, 2021 -- Silo Pharma, Inc. (OTCQB: SILO) a development stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has submitted its initial application to list on the NASDAQ Capital Market (“NASDAQ”).The Company previously announced its board approval to... Read More...
28 views2 min read

Silo Pharma Announces Collaboration with University California San Francisco to study Psilocybin as an Anti-Inflammatory agent in Parkinson’s and Bipolar Patients

Silo Pharma
Englewood Cliffs, NJ, June 08, 2021 -- Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has entered into a Scientific Research Agreement (SRA) with the University of California San Francisco (UCSF). This SRA will leverage four ... Read More...
Joint Venture65 views5 min read

Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India

Revive Therapeutics
TORONTO, June 08, 2021 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, Frankfurt: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into a memorandum of understanding dated June 7, 2021 w... Read More...
56 views6 min read

Psyence Group Corporate Update

Psyence Group
TORONTO, May 27, 2021 -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”) is pleased to provide the following corporate update on its three clear paths to revenue and value creation namely: Psyence Production, Psyence Therapeutics and Psyence Function.Psyence ProductionPsyence is federally licensed to cultivate and export psilo... Read More...
73 views4 min read

The Psyence Group Announces its Formal Entry into Jamaica with the Incorporation of its Wholly Owned Subsidiary, Psyence Jamaica Limited

Psyence Group
TORONTO, June 08, 2021 -- Psyence Group Inc. (“Psyence” or the “Company”) (PSYG:CSE), a Canadian public biotechnology company with a global presence, is pleased to announce the incorporation, and operational commencement, of its wholly owned Jamaican subsidiary, “Psyence Jamaica Limited” (“Psyence Jamaica”).The Psyence Group has been oper... Read More...
1346 views5 min read

PharmaDrug Signs Supply Agreement with European Cannabis Extractor for Medical Grade THC Oil to Be Sold Under PharmaDrug Brand

Pharmadrug
Toronto, Ontario--(Newsfile Corp. - May 14, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, ... Read More...
72 views4 min read

Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products

Lobe Sciences
Natural health products will be manufactured and packaged by HAVN LifeVancouver, British Columbia--(Newsfile Corp. - May 19, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce it has entered into a production and supply agreement (the "Agreement") on May 14, 2021 with HAVN Life Scienc... Read More...
140 views4 min read

Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences and Silo Wellness Announces Psychedelics Genetic Test Kit Partnership

Entheon Biomedical
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon"), a biotechnology company focused on developing psychedelic medicines to treat addiction, and Silo Wellness Inc. (CSE: SILO) (OTC: SILFF) (FSE:3K70) ("Silo Wellness"), a functional and psilocybin mushr... Read More...
61 views5 min read

Silo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces Psychedelics Genetic Test Kit Partnership

Entheon Biomedical
TORONTO, June 17, 2021 -- Silo Wellness Inc. (“Silo Wellness” or “the Company”) (CSE: SILO) (FRA: 3K70) (OTC: SILFF), a functional and psilocybin mushroom company offering psychedelic wellness retreats, and Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon"), a biotechnology company focused on developing psychedeli... Read More...
31 views4 min read

Bright Minds Biosciences Appoints New Board Member and Expands Leadership Team

Bright Minds Biosciences
Additions of industry veterans, Dr. Emer Leahy to the Board of Directors and Dr. Tom Lategan as Vice President of Regulatory Affairs, position the Company to advance drug development programsVANCOUVER, British Columbia, June 14, 2021 -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE:DRUG) (OTCQB:BMBIF), a biotechno... Read More...
80 views9 min read

Canbud Distribution Clarifies Previous Disclosure

Canbud Distribution
Toronto, Ontario--(Newsfile Corp. - May 20, 2021) - Canbud Distribution Corporation (CSE: CBDX) (the "Corporation") announces that, as a result of a review of its continuous disclosure record by the Ontario Securities Commission (the "OSC"), the Corporation is issuing this news release to clarify certain disclosures made in its news relea... Read More...
LOIM & A121 views7 min read

Canbud Distribution Enters into Letter of Intent to Acquire Molecular Science Corp.

Canbud Distribution
Toronto, Ontario--(Newsfile Corp. - May 27, 2021) - Canbud Distribution Corp. (CSE: CBDX) (FSE: CD0) (the "Corporation") is pleased to announce that, on May 25, 2021, it has entered into a non-binding Letter of Intent (the "Letter of Intent") with Molecular Science Corp. ("MSC") in respect of a proposed transaction (the "Proposed Transact... Read More...
29 views4 min read

BetterLife Pharma Retains Proactive Investors and Psychedelic Finance for Market Awareness

BetterLife Pharma
VANCOUVER, British Columbia, June 10, 2021 -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce that it has retained Proactive Investors (“Proactive”) and Psychedelic Finance to broaden the Company's reach within a global investor network, as... Read More...
41 views7 min read

Allied Corp Expands Cannabis Production and Inventory Capacity

Allied
KELOWNA, British Columbia, June 03, 2021 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health solutions to address today’s medical mental health issues is pleased to announce progress on its 2021 expansion. Construction has commenced on an additional 200,000 sq... Read More...
Uncategorized37 views4 min read

Algernon Pharmaceuticals Highlights New Animal Study Showing Effectiveness of Psychedelic Drug DMT in Treatment of Stroke

VANCOUVER, British Columbia, May 27, 2021 -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) is pleased to highlight an independent research study from the University of Szeged in Hungary describing the use of N,N-dimethyltryptamine (“DMT”) in improving outcomes in a rat stroke model.... Read More...
Uncategorized34 views4 min read

Algernon Pharmaceuticals Launches Pancreatic Cancer Clinical Research Program with Ifenprodil

VANCOUVER, British Columbia, June 03, 2021 -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) announces it has initiated a new clinical research program for pancreatic cancer (PC) and NP-120 (Ifenprodil). Ifenprodil demonstrated a significant anti-tumour effect in a PC animal model wh... Read More...
Uncategorized31 views4 min read

Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021

VANCOUVER, British Columbia, June 17, 2021 -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) is pleased to announce that all of the required permits and licenses for the manufacture of its cGMP supply of AP-188 (“N, N-Dimethyltryptamine or DMT”) have been received and as a result, is... Read More...
Featured61 views5 min read

COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers

COMPASS Pathways plc
LONDON, June 03, 2021 -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has reported further results from a phase I study showing that its COMP360 psilocybin had no clinically-relevant negative effect on cognitive functio... Read More...
46 views5 min read

Germinator and AREV Nanotech Brands Inc. Sign Distribution Agreement to Provide the Genesis Platform of Surface Disinfection to Global Public Health Commodity Procurement Programs

AREV Life Sciences Global
The partnership will help serve a dire need for surface disinfectant treatments to prevent the spread of highly infectious diseases to vulnerable populations in developing nationsVANCOUVER, British Columbia, June 03, 2021 -- AREV Nanotech Brands, Inc. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) ("AREV" or the “Company"), a publicly traded life ... Read More...
46 views4 min read

AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins For Use in Its Ready-To-Use Therapeutic Foods

AREV Life Sciences Global
VANCOUVER, British Columbia, June 16, 2021 -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) Through its subsidiary AREV Cambodia is pleased to announce the Company has completed its land survey and soil analysis for cultivation of mushrooms, moringa and breadfruit.Mr. Rem Sareub, Head of Agriculture for AREV ... Read More...
12 views4 min read

MINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and Depression

Mind Cure Health
MINDCURE will distribute these protocols to therapists through iSTRYM, its digital therapeutics platform. This milestone in protocol development unlocks the company's protocol distribution platform in time for iSTRYM's clinical MVP launch in Q3 2021. VANCOUVER, BC, June 17, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH... Read More...
332 views4 min read

PharmaTher To Present At The H.C. Wainwright Psychedelics In Psychiatry And Beyond Virtual Conference

PharmaTher Holdings
TORONTO, June 16, 2021 -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, today announced that Fabio Chianelli, Chief Executive Officer, will be presenting at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17, 2021. Th... Read More...
Featured37 views6 min read

MindMed Announces Chief Executive Officer Transition

NEW YORK, June 9, 2021 -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading clinical-stage pharmaceutical company and pioneer in the field of psychedelic inspired medicines, announces that J.R. Rahn, the Company's co-founder and chief executive officer, is stepping down as chief executive offic... Read More...
M & A4 views9 min read

Leading Psychedelic Wellness Company Delic Signs Definitive Agreement to Acquire Ketamine Infusion Centers Llc, Bringing Physical Retail Chain to Delic Portfolio

Delic Holdings
Acquisition to Expand Self-Sustaining Ecosystem with Existing Education Platform and Product Development Lab VANCOUVER, BC, June 8, 2021 - Delic Holdings Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform has signed a definitive agreement (the "Agreement") to acquire Ketamine Infusion C... Read More...
1 views4 min read

MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

Mind Cure Health
By manufacturing ibogaine, MINDCURE's research team will have access to a predictable and standardized supply of synthetic ibogaine while ensuring consistent dosing and reliable results. VANCOUVER, BC, June 3, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!